Cambria R P, Brewster D C, L'Italien G J, Moncure A, Darling R C, Gertler J P, La Muraglia G M, Atamian S, Abbott W M
Division of Vascular Surgery, Massachusetts General Hospital, Boston.
J Vasc Surg. 1994 Jul;20(1):76-85; discussion 86-7. doi: 10.1016/0741-5214(94)90178-3.
Among various surgical techniques for renal artery reconstruction (RAR), anatomic aortorenal bypass has been the preferred standard. Yet concern regarding origin of the bypass from a diseased aorta and desire to avoid a major aortic operation in these patients who are often at poor risk has led to increasing use of extraanatomic bypass grafting, particularly hepatorenal and splenorenal bypass. This study was conducted to compare the safety and long-term performance of these different techniques of renal artery reconstruction.
We reviewed a 15-year (1976 to 1991) experience with 323 surgical RAR performed in 285 patients with atherosclerotic renovascular disease. Long-term patency and survival rates were analyzed by life-table methods. Variables potentially affecting early failure of the RAR and perioperative and late mortality rates were examined by Cox proportional hazards models.
Diffuse atherosclerosis characterized the patients' clinical profile. Clinically evident coronary artery disease was present in 54% of patients, and some degree of renal insufficiency was present in 60%. Ninety-five percent of patients had hypertension with poor control of hypertension seen in 50%. Aortic disease necessitated combined aortic grafting and RAR in 43% of the study group. Various techniques of RAR were used as follows: endarterectomy or patch angioplasty, 8.5%; extraanatomic bypass grafting, 37% (hepatorenal, 62; splenorenal, 52; iliorenal, 7); and aortorenal bypass grafting, 54% (native aorta, 34; combined aortic graft and RAR, 140). Early failure of the RAR occurred in 5% of cases, and the operative mortality rate for the entire cohort was 5.6%. Median follow-up duration was 9.4 years. A comparison of early and late patency for the major types of RAR revealed equivalent (p = 0.44) performance of aortorenal and extraanatomic bypass grafting. Perioperative complications occurred more frequently (p < 0.02) in patients undergoing combined operations. The cumulative 5-year survival rate for all patients was 75%.
Because extraanatomic bypass grafting can provide long-term results equivalent to aortorenal bypass grafting, the choice among techniques for RAR in patients with diffuse atherosclerosis should be based on both technical and operative safety considerations, rather than adherence to aortorenal bypass grafting as an inherently superior technique.
在肾动脉重建(RAR)的各种手术技术中,解剖性主动脉-肾动脉旁路移植术一直是首选的标准术式。然而,对于旁路血管起源于病变主动脉的担忧,以及希望避免在这些通常风险较高的患者中进行大型主动脉手术,导致解剖外旁路移植术的应用日益增加,尤其是肝-肾和脾-肾旁路移植术。本研究旨在比较这些不同肾动脉重建技术的安全性和长期疗效。
我们回顾了1976年至1991年15年间对285例患有动脉粥样硬化性肾血管疾病患者实施的323例外科RAR手术的经验。采用寿命表法分析长期通畅率和生存率。通过Cox比例风险模型检查可能影响RAR早期失败、围手术期和晚期死亡率的变量。
患者的临床特征以弥漫性动脉粥样硬化为特点。54%的患者存在临床明显的冠状动脉疾病,60%的患者存在一定程度的肾功能不全。95%的患者患有高血压,其中50%的患者高血压控制不佳。43%的研究组患者因主动脉疾病需要联合主动脉移植和RAR。RAR的各种技术使用情况如下:内膜切除术或补片血管成形术,8.5%;解剖外旁路移植术,37%(肝-肾旁路62例;脾-肾旁路52例;髂-肾旁路7例);主动脉-肾动脉旁路移植术,54%(自体主动脉34例;联合主动脉移植和RAR 140例)。RAR早期失败发生在5%的病例中,整个队列的手术死亡率为5.6%。中位随访时间为9.4年。对主要类型的RAR早期和晚期通畅情况的比较显示,主动脉-肾动脉旁路移植术和解剖外旁路移植术的疗效相当(p = 0.44)。联合手术患者围手术期并发症发生率更高(p < 0.02)。所有患者的5年累积生存率为75%。
由于解剖外旁路移植术可提供与主动脉-肾动脉旁路移植术相当的长期效果,对于弥漫性动脉粥样硬化患者,RAR技术的选择应基于技术和手术安全性考虑,而非坚持认为主动脉-肾动脉旁路移植术本质上是更优越的技术。